Stuart Poulton
Corporate Officer/Principal bei KARYOPHARM THERAPEUTICS INC.
Vermögen: 497 562 $ am 31.03.2024
Profil
Stuart Poulton is currently the Chief Development Officer & Executive VP at Karyopharm Therapeutics, Inc. Prior to his current position, he worked as the Executive Director-Global Program Management at Amgen, Inc. from 2013 to 2016.
He also held the position of Head-Clinical Operations at Eli Lilly & Co. Additionally, Mr. Poulton served as the Vice President-Clinical Development Operations at AbbVie, Inc. from 2019 to 2022.
He completed his graduate degree at The University of New South Wales and his undergraduate degree at The University of Sydney.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 329 511 ( 0,29% ) | 497 562 $ | 31.03.2024 |
Aktive Positionen von Stuart Poulton
| Unternehmen | Position | Beginn |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 01.02.2022 |
Ehemalige bekannte Positionen von Stuart Poulton
| Unternehmen | Position | Ende |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01.01.2022 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2016 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Stuart Poulton
| The University of New South Wales | Graduate Degree |
| The University of Sydney | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| ABBVIE INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
